RBP4

retinol binding protein 4, the group of Lipocalins

Basic information

Region (hg38): 10:93591687-93601744

Links

ENSG00000138207NCBI:5950OMIM:180250HGNC:9922Uniprot:P02753AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • microphthalmia, isolated, with coloboma 10 (Strong), mode of inheritance: AD
  • microphthalmia, isolated, with coloboma (Supportive), mode of inheritance: AD
  • progressive retinal dystrophy due to retinol transport defect (Supportive), mode of inheritance: AR
  • microphthalmia, isolated, with coloboma 10 (Moderate), mode of inheritance: AR
  • progressive retinal dystrophy due to retinol transport defect (Definitive), mode of inheritance: AR
  • microphthalmia, isolated, with coloboma 10 (Strong), mode of inheritance: AD
  • progressive retinal dystrophy due to retinol transport defect (Strong), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Microphthalmia/coloboma 10; Retinol dystrophy, iris coloboma, and comedogenic acne syndromeAD/ARGeneralGenetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testingDermatologic; Ophthalmologic9888420; 2886863; 1293390; 23189188; 25910211
It has been suggested that high-dose vitamin A supplementation may be beneficial in Retinol dystrophy, iris coloboma, and comedogenic acne syndrome

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the RBP4 gene.

  • not provided (4 variants)
  • Bilateral microphthalmos (1 variants)
  • Progressive retinal dystrophy due to retinol transport defect (1 variants)
  • Microphthalmia, isolated, with coloboma 10 (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the RBP4 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
40
clinvar
1
clinvar
41
missense
1
clinvar
9
clinvar
66
clinvar
76
nonsense
3
clinvar
3
start loss
1
clinvar
1
frameshift
1
clinvar
1
inframe indel
0
splice donor/acceptor (+/-2bp)
1
clinvar
3
clinvar
4
splice region
6
2
8
non coding
14
clinvar
16
clinvar
30
Total 6 12 67 54 17

Highest pathogenic variant AF is 0.00000657

Variants in RBP4

This is a list of pathogenic ClinVar variants found in the RBP4 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
10-93592093-T-C Likely benign (May 21, 2023)2866709
10-93592104-C-T Uncertain significance (Aug 31, 2020)1057567
10-93592105-G-A Likely benign (Aug 14, 2023)1136472
10-93592113-C-T Microphthalmia, isolated, with coloboma 10 Likely pathogenic (May 15, 2020)929566
10-93592121-T-TA Likely benign (Oct 05, 2022)1577227
10-93592193-A-G Benign (May 25, 2021)1263116
10-93593731-C-T Benign (May 15, 2021)1247112
10-93593756-G-A Benign (May 15, 2021)1282263
10-93593813-C-T Likely benign (Mar 09, 2021)1539479
10-93593816-G-T Likely benign (Nov 15, 2022)2892694
10-93593818-C-A Uncertain significance (Aug 10, 2020)1057428
10-93593818-C-G Uncertain significance (Mar 18, 2023)1896307
10-93593823-C-T Uncertain significance (Oct 09, 2023)1413985
10-93593824-G-A Uncertain significance (Jan 15, 2024)1017235
10-93593825-T-C Inborn genetic diseases Uncertain significance (Oct 24, 2023)839508
10-93593828-T-C Uncertain significance (Apr 09, 2023)1019998
10-93593832-C-T Conflicting classifications of pathogenicity (Jan 12, 2024)1013571
10-93593833-G-A Likely benign (Nov 23, 2022)2162227
10-93593847-G-T Inborn genetic diseases Uncertain significance (Mar 01, 2024)289619
10-93593848-C-T Likely benign (Sep 15, 2022)2011541
10-93593862-G-A Likely benign (Dec 04, 2022)2796874
10-93593863-C-A Inborn genetic diseases Uncertain significance (Jan 15, 2024)943659
10-93593865-C-A Progressive retinal dystrophy due to retinol transport defect Pathogenic (Mar 17, 2020)976725
10-93593868-C-T Uncertain significance (Jul 05, 2022)1378995
10-93593873-C-T Uncertain significance (Dec 03, 2023)2069421

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
RBP4protein_codingprotein_codingENST00000371467 510058
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.5200.477125739031257420.0000119
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.775981220.8030.000007581316
Missense in Polyphen3551.7660.67611561
Synonymous0.0008075555.01.000.00000390377
Loss of Function2.45210.60.1895.07e-7110

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.00002920.0000292
Ashkenazi Jewish0.000.00
East Asian0.000.00
Finnish0.000.00
European (Non-Finnish)0.00001800.0000176
Middle Eastern0.000.00
South Asian0.000.00
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Retinol-binding protein that mediates retinol transport in blood plasma (PubMed:5541771). Delivers retinol from the liver stores to the peripheral tissues (Probable). Transfers the bound all-trans retinol to STRA6, that then facilitates retinol transport across the cell membrane (PubMed:22665496). {ECO:0000269|PubMed:22665496, ECO:0000305, ECO:0000305|PubMed:5541771}.;
Disease
DISEASE: Retinal dystrophy, iris coloboma, and comedogenic acne syndrome (RDCCAS) [MIM:615147]: A disease characterized by retinal degeneration, ocular colobomas involving both the anterior and posterior segment, impaired night vision and loss of visual acuity. Additional characteristic features include developmental abnormalities and severe acne. {ECO:0000269|PubMed:10232633, ECO:0000269|PubMed:23189188, ECO:0000269|PubMed:9888420}. Note=The disease is caused by mutations affecting the gene represented in this entry. Loss of functional RBP4 protein results in serum retinol deficiency. Lack of normal levels of retinol impairs the visual cycle leading to night blindness at early stages; prolonged deficiency may lead to retinal degeneration. Additionally, retinol deficiency may result in dry skin, increased susceptibility to infection and acne (PubMed:23189188). {ECO:0000269|PubMed:23189188}.; DISEASE: Microphthalmia, isolated, with coloboma, 10 (MCOPCB10) [MIM:616428]: A disorder of eye formation, ranging from small size of a single eye to complete bilateral absence of ocular tissues. Ocular abnormalities like opacities of the cornea and lens, scaring of the retina and choroid, and other abnormalities may also be present. Ocular colobomas are a set of malformations resulting from abnormal morphogenesis of the optic cup and stalk, and the fusion of the fetal fissure (optic fissure). {ECO:0000269|PubMed:25910211}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Pathway
Sterol Regulatory Element-Binding Proteins (SREBP) signalling;Vitamin A and Carotenoid Metabolism;Signaling by GPCR;Signal Transduction;Metabolism of fat-soluble vitamins;Metabolism;The canonical retinoid cycle in rods (twilight vision);Metabolism of vitamins and cofactors;retinoate biosynthesis II;retinoate biosynthesis I;retinol biosynthesis;Retinoid metabolism and transport;G alpha (i) signalling events;Visual phototransduction;the visual cycle I (vertebrates);GPCR downstream signalling (Consensus)

Intolerance Scores

loftool
0.159
rvis_EVS
-0.47
rvis_percentile_EVS
23.04

Haploinsufficiency Scores

pHI
0.514
hipred
Y
hipred_score
0.830
ghis
0.962

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.928

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Rbp4
Phenotype
renal/urinary system phenotype; skeleton phenotype; vision/eye phenotype; digestive/alimentary phenotype; limbs/digits/tail phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); reproductive system phenotype; normal phenotype; homeostasis/metabolism phenotype; cellular phenotype; muscle phenotype; endocrine/exocrine gland phenotype;

Zebrafish Information Network

Gene name
rbp4
Affected structure
post-vent region
Phenotype tag
abnormal
Phenotype quality
morphology

Gene ontology

Biological process
retinoid metabolic process;eye development;gluconeogenesis;heart development;visual perception;maintenance of gastrointestinal epithelium;lung development;positive regulation of insulin secretion;response to retinoic acid;retinol transport;retinol metabolic process;glucose homeostasis;response to ethanol;embryonic organ morphogenesis;embryonic skeletal system development;cardiac muscle tissue development;female genitalia morphogenesis;positive regulation of immunoglobulin secretion;negative regulation of cardiac muscle cell proliferation;embryonic retina morphogenesis in camera-type eye;uterus development;vagina development;urinary bladder development;heart trabecula formation
Cellular component
extracellular region;extracellular space;cytosol;protein-containing complex;extracellular exosome
Molecular function
protein binding;retinal binding;retinol binding;retinol transmembrane transporter activity;protein heterodimerization activity